Stem Cell Banking Market to Surpass Value of USD 18.65 Billion By 2031 | SkyQuest Technology
SkyQuest Technology Consulting Pvt. Ltd.
SkyQuest Technology Consulting Pvt. Ltd.

The stem cell banking market is growing due to advancements in cryopreservation, cell bank prep, monoclonal antibodies, and the rising adoption of stem cell therapy.

Westford, USA, Dec. 15, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global stem cell banking market share will reach a value of USD 18.65 Billion by 2031, with a CAGR of 18.30% during the forecast period (2024-2031). As cryopreservation and cell bank preparation techniques are getting advanced, the stem cell banking market is expanding rapidly. Besides, the market is growing due to the increased application of stem cell treatment and the trend of monoclonal antibodies with effective biopharmaceuticals. Furthermore, with the fact that more couples are opting for children at a later stage in life, late parenting is on the rise, and it has generated interest in cord blood banking. Biological insurance makes parents realize that their babies' cord blood stem cells need to be protected. Thus, the global stem cell banking market growth is boosting.

Browse in-depth TOC on the "Stem Cell Banking Market"

Pages – 188

Tables – 89

Figures – 72

To Learn More About This Report, Request a Free Sample Copy - https://www.skyquestt.com/sample-request/stem-cell-banking-market

Stem Cell Banking Market Overview:

Report Coverage 

Details 

Market Revenue in 2023

USD 9.85 Billion

Estimated Value by 2031

USD 18.65 Billion

Growth Rate

Poised to grow at a CAGR of 18.30%

Forecast Period

2024–2031

Forecast Units

Value (USD Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Source, Service Type, Application, and Region

Geographies Covered

North America, Europe, Asia Pacific, Middle East & Africa, Latin America

Report Highlights

Stem cell banking market shows significant growth potential

Key Market Opportunities

Personalized Medicine Trends

Key Market Drivers

Rising Awareness of Stem Cell Therapy

Adipose Tissue-Derived Stem Cells Supporting Growth with Higher Availability and Minimal Invasiveness

Based on the 2023 stem cell banking market analysis, adipose tissue-derived stem cells, or ADSCs, providing more production and greater availability, are anticipated to emerge as one of the major segments in the market. Compared to other stem cell sources, such as bone marrow or embryos, these cells are more patient friendly since they would be collected by minimal effort on minimally invasive means. The promise that ADSCs must regenerate with respect to wound healing, tissue regeneration, and clinical cosmetic applications has motivated the increased number of research and positioned them first among the current choices of stem cell therapy.